Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07393841 · ClinicalTrials.gov registry record
Molecular Indicators of Systematic Fitness
A clinical trial of Aging and Healthy Adult, sponsored by VO Health.
- Recruiting
- Registry status
- 250
- Enrollment target
- 1
- Study location
NCT07393841: Recruiting study of Aging and Healthy Adult, sponsored by VO Health.
NCT07393841 is a study of Aging and Healthy Adult that is actively recruiting participants, run by VO Health. The registered enrollment target is 250 participants, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07393841, a study of Aging and Healthy Adult, is actively recruiting participants, sponsored by VO Health.
- RECRUITING
- Registry status
- 250 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the same day. The main questions it aims to answer are: 1. Can a multi-analyte blood panel accurately predict directly measured VO₂max/VO₂peak? 2. How do these blood-based features vary across age, sex, and self-reported or documented physical activity profiles? 3. Are the predictor analytes able to capture changes in VO₂max/VO₂peak caused by a self-directed intervention (e.g., training for a marathon)? 4. What is the analytic reliability of the predictor biomarkers?
Primary Outcome
The primary outcome is developing a multi-protein biomarker panel that can accurately estimate cardiorespiratory fitness from the blood.
Conditions Studied
Interventions
- OTHER There is no intervention.
Study Locations (1)
Connecticut
- VO Health, Inc. - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2026-01-05 |
| Est. Completion | 2028-05-10 |
What NCT07393841 shows while recruiting
NCT07393841 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,194-participant average among 262 other Aging trials with a reported enrollment target (89% lower).
The record links to 6 conditions, with Aging appearing as the primary indexed condition, and to 1 intervention - of which There is no intervention. is the first listed.
NCT07393841 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT07393841 about?
NCT07393841 is a clinical study titled "Molecular Indicators of Systematic Fitness". The goal of this study is to characterize associations between cardiorespiratory fitness, as measured by VO₂max/VO₂peak, and blood-based molecular measurements in adults. This is an observational study where research staff measures VO₂max/VO₂peak and collects fasted, resting blood samples on the sam...
What is the current status of trial NCT07393841?
This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2026-01-05. Estimated completion is 2028-05-10.
What conditions does trial NCT07393841 study?
This clinical trial studies the following conditions: Aging, Healthy Adult, Athlete, Fitness Testing, Exercise Physiology.
What interventions are being tested in trial NCT07393841?
The interventions under investigation include: There is no intervention. (OTHER).
Who is sponsoring clinical trial NCT07393841?
This trial is sponsored by VO Health, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07393841 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07393841's enrollment target sits among peer trials
250 39th of 262 higher than 223 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
The Role of Neutrophils in the Age-driven Decline in Anti-pneumococcal Vaccine Responses
RECRUITING · Phase 4
-
Effect of a Daily Supplement on Plasma PAI-1 Levels
RECRUITING · Phase 1
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI